Navigation Links
New federal disclosure law may have little impact on drugs prescribed
Date:5/29/2012

AURORA, Colo. (May 29, 2012) A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.

"If the policymakers who passed these measures were hoping for a deterrent effect they may be disappointed," said the study's lead author, Genevieve Pham-Kanter, Ph.D., an assistant professor in the Department of Health Systems, Management and Policy at the Colorado School of Public Health and a research fellow at Harvard University and Massachusetts General Hospital.

The report, published Monday in the Archives of Internal Medicine, was prompted by passage of the Physician Payments Sunshine Provision of the Affordable Care Act.

The new federal law requires drug manufacturers to disclose certain payments made to physicians including money for consulting, honoraria, gifts and travel.

"This law is based on the premise that transparency in these transactions is of public importance and that disclosure requirements can act as a deterrent against quid pro quo exchanges physicians may be reluctant to accept large payments from pharmaceutical firms if payments are publicly known and perceived as financial compensation for prescribing certain therapies," said Pham-Kanter who is also an assistant professor of economics at the University of Colorado Denver.

Working with Kavita Nair, Ph.D., associate clinical professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and G. Caleb Alexander, MD, MS, Johns Hopkins Bloomberg School of Public Health, Pham-Kanter examined West Virginia and Maine, two states with disclosure laws already on the books.

She specifically investigated the effect of the laws on the prescribing of HMG-CoA reductase inhibitors (statins) and selective serotonin reuptake inhibitors (SSRIs). Marketing plays a heavy role in
'/>"/>

Contact: David Kelly
david.kelly@ucdenver.edu
303-315-6374
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Federal grant enables HIV testing, treatment in the Augusta area
2. Study finds federal amendments increased gun sales diverted to criminals
3. UofL geriatrician selected for new federal Innovation Advisors Program
4. Cleveland Clinic nephrologist earns Federal grant for study of kidney disease management
5. Requests for Alzheimers disease research grants up by 33 percent, as federal funding in doubt
6. Federal government releases environmental, health, and safety research strategy for nanotechnology
7. Hasbro Childrens Hospital now part of nations first federally- funded pediatric research network
8. Radiologists urged to study federal regulations relating to meaningful use
9. Federal investment in electronic health records likely to reap returns in quality of care
10. Pro athletes ought to bargain outside federal court, legal scholar says
11. CMAJ calls on federal government to protect Canadians from unsafe drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... hormone therapy has spawned a prevalent but preventable side ... flashes, according to a study by a Yale School ... study published in the Aug. 27 online issue of ... moderate to severe hot flashes also called vasomotor ... Women with VMS experience more than feeling hot; other ...
(Date:8/27/2014)... (PDT, which uses topical agents and light to kill ... common skin lesion caused by sun damage) at three ... to freeze lesions). , Author: Gayatri Patel, ... Center, in Sacramento, and colleagues. , Background: ... found on individuals with fair complexions who have had ...
(Date:8/27/2014)... Warren, MI (PRWEB) August 27, 2014 Michigan ... to help the children of a local elementary school by ... year. Siersma Elementary School has year-round attendance, and Michigan Head ... equipped to meet the new school year. , "There are ... think this is a great way to give back to ...
(Date:8/27/2014)... 2014 Dr. Stewart Shofner ... multitudes of patients suffering from impaired vision. Some of ... vision correction surgery . Recently, Dr. Shofner has noticed ... an eye exam and also online. To help patients ... myths about glaucoma. , 1)    Myth: People with perfect vision ...
(Date:8/27/2014)... Washington, New York (PRWEB) August 27, 2014 ... dedicated to protecting the rights of victims injured by ... new rules in place for discovery procedures, specifically Collection ... brought over C.R. Bard’s transvaginal mesh devices. (MDL No. ... Products Liability Litigation, the United States District Court, Southern ...
Breaking Medicine News(10 mins):Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4
... for Gerontology in Higher Education (AGHE) the educational ... will hold its 37th Annual Meeting and Educational Leadership ... Hilton Cincinnati Netherland Plaza in Cincinnati, OH. Media ... This conference provides a forum for professionals in the field ...
... , THURSDAY, Feb. 24 (HealthDay News) -- Fewer men ... (PSA) screening for prostate cancer since the release of guidelines ... few years ago, say researchers. This study examined ... decline in PSA screening was three percent among men aged ...
... University of Maryland-led team of scientists indicate that a ... antibody or a scorpion anti-malarial toxin could be ... combating malaria, at a time when the effectiveness of ... a study published in the February 25 issue of ...
... Administration and Georgetown University Medical Center (GUMC) today announced ... ethics, education, and training. The partnership enhances the capabilities ... improving public health. "We are excited about this ... goal of translating basic research discoveries into real world ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, Feb. ... the immune systems of HIV patients and may stave off ... to recommend the drug for this purpose, the findings of ... drugs that can help adjust the immune response in HIV ...
... donor-liver distribution network developed by University of Pittsburgh researchers ... receiving the transplants they need. The team reports ... donor livers currently are doled out to 11 national ... demographics, an arrangement that prevents many livers from getting ...
Cached Medicine News:Health News:As America's senior population grows, meeting to outline effective education about aging 2Health News:PSA Screening for Prostate Cancer Dips in Large U.S. Health Network 2Health News:New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases 2Health News:New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases 3Health News:New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases 4Health News:FDA and Georgetown University Medical Center announce partnership 2Health News:Statins Might Help HIV Patients, Study Suggests 2Health News:Redesign of US donor-liver network could boost transplants by several hundred per year 2Health News:Redesign of US donor-liver network could boost transplants by several hundred per year 3
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)... Pa. , Aug. 27, 2014   Auxilium Pharmaceuticals ... integrated specialty biopharmaceutical company, today announced that certain members ... Morgan Stanley Healthcare Conference to be held September 8-10, ... Adrian Adams , Chief Executive Officer and President, is ... its product portfolio at 10:55 a.m. ET on Wednesday, ...
(Date:8/27/2014)... Asterias Biotherapeutics Inc. (OTCBB: ASTY) has received ... to initiate a Phase 1/2a clinical trial of its ... injury.  The approved trial follows the successful completion of ... is designed to assess safety and activity of escalating ... cord injuries, the first targeted indication for AST-OPC1 and ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5
... IRVINE, Calif., Aug. 11, 2011 ChromaDex Corporation ... provides proprietary, science-based solutions and ingredients to the ... industries, today announced financial results for the second ... calculated in accordance with U.S. Generally Accepted Accounting ...
... 2011 Reportlinker.com announces that a ... available in its catalogue: ... - Global Opportunity Assessment, Competitive ... 2017 ...
Cached Medicine Technology:ChromaDex Announces Financial Results for Second Quarter 2011 2ChromaDex Announces Financial Results for Second Quarter 2011 3ChromaDex Announces Financial Results for Second Quarter 2011 4Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 2Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 3Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 4Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 5Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 6Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 7Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 8Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 9Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 10
... is the First and Only ... the powerful technology of RESTORE with ... to create the unrivaled RESTOREPRIME. The ... and coverage for managing patients with ...
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... Atlas II HF systems are intended to ... for automated treatment of life-threatening ventricular arrhythmias. ... Atlas II HF systems are also intended:, ... symptoms of moderate to severe heart failure ...
Medicine Products: